TABLE 1.
Primers used in the construction and testing of mchI expression plasmids
Primer | Sequencea | Cassette created | Templateb | Reference or source |
---|---|---|---|---|
1 | 5′-GCTAGCGGGCACCCCAGGCTTTCCACTTTATGCTTCCGGCTCGTATAATGTGTGGAATCT-3′ | lacUV5 promoter variant 33C | NA | 18 |
2 | 5′-TAACTCATTTTTTTTTCCTCCTTATTTTCTAGATTCCACACATTATACGAGCCGGAAGCA-3′ | lacUV5 promoter variant 33C | NA | 18 |
3 | 5′-TCTAGAAAATAAGGAGGAAAAAAAAATGAGTTATAAAAAACTGTACCAATTGACGGCTATAT-3′ | mchI | RYC1000(pEX4) | 37 |
4 | 5′-GCTAGCCTATTAACTTCCGTTTTTCCAGCCTGACCAGACCAAAATCTTTCGAATCCCATGA-3′ | mchI | RYC1000(pEX4) | 37 |
5 | 5′-GTAAACTTGGTCTGACAGGTACCAATGCTTAATCAGTG-3′ | pGENMch | This study | |
6 | 5′-CACTGATTAAGCATTGGTACCTGTCAGACCAAGTTTAC-3′ | pGENMch | This study | |
7 | 5′-CAAATAGGGGTACCGCGCACATTTCCCCG-3′ | pGENMch | This study | |
8 | 5′-CGGGGAAATGTGCGCGGTACCCCTATTTG-3′ | pGENMch | This study |
Relevant restriction sites are designated in boldface (see the text for details); ribosome binding sites and start codons are in italics.
NA, not applicable.